ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Pennsylvania » Internal Medicine

Top Internal Medicine Prescribers in Pennsylvania

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
MICHAEL FROST M.D.

Internal Medicine

0

$0

0
0 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

0%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

0%
prescriptions for brand name drugs

Avg: 25%

$0
Average prescription price

Avg: $58

ABIMBOLA TALABI M.D.

Internal Medicine

82

$22.4K

27
0 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

89%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

87%
prescriptions for brand name drugs

Avg: 25%

$273
Average prescription price

Avg: $58

ERICA ZIMMERMAN MD

Internal Medicine

91

$29.9K

22
0 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

68%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

86%
prescriptions for brand name drugs

Avg: 25%

$329
Average prescription price

Avg: $58

TIMOTHY REESE M.D.

Internal Medicine

158

$22.8K

14
0 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

79%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

84%
prescriptions for brand name drugs

Avg: 25%

$145
Average prescription price

Avg: $58

CURTIS PETERSON MD

Internal Medicine

174

$1,626

136
89 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

38%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

6%
prescriptions for brand name drugs

Avg: 25%

$9
Average prescription price

Avg: $58

PHILLIP LEVINE M.D.

Internal Medicine

176

$54.9K

20
0 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

85%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

84%
prescriptions for brand name drugs

Avg: 25%

$312
Average prescription price

Avg: $58

JAMES BLAKE DO

Internal Medicine

211

$17.1K

98
75 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

0%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

42%
prescriptions for brand name drugs

Avg: 25%

$81
Average prescription price

Avg: $58

VEENA DEVARAKONDA M.D,

Internal Medicine

238

$59.2K

54
42 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

0%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

82%
prescriptions for brand name drugs

Avg: 25%

$249
Average prescription price

Avg: $58

ANDREA MANNI MD

Internal Medicine

242

$26.3K

47
29 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

0%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

54%
prescriptions for brand name drugs

Avg: 25%

$109
Average prescription price

Avg: $58

VASUKI DANDU MD

Internal Medicine

244

$33.3K

34
12 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

0%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

13%
prescriptions for brand name drugs

Avg: 25%

$137
Average prescription price

Avg: $58

RONALD FILIPPI MD

Internal Medicine

244

$4,748

174
120 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

16%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 25%

$19
Average prescription price

Avg: $58

JO-ANNE STEWARD M.D.

Internal Medicine

248

$7,357

172
142 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

0%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

32%
prescriptions for brand name drugs

Avg: 25%

$30
Average prescription price

Avg: $58

OLA KANJ AHMED MD

Internal Medicine

249

$122K

46
38 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

0%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 25%

$488
Average prescription price

Avg: $58

SONALI SAKARIA

Internal Medicine

258

$26.5K

98
59 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

0%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

38%
prescriptions for brand name drugs

Avg: 25%

$103
Average prescription price

Avg: $58

HUUB MULDERS MD

Internal Medicine

258

$15.5K

47
37 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

0%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

16%
prescriptions for brand name drugs

Avg: 25%

$60
Average prescription price

Avg: $58

CHETAN NAIK M.D

Internal Medicine

270

$75.1K

92
68 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

0%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

68%
prescriptions for brand name drugs

Avg: 25%

$278
Average prescription price

Avg: $58

MATTHEW NIKOLOFF M.D.

Internal Medicine

284

$21.8K

140
100 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

0%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

42%
prescriptions for brand name drugs

Avg: 25%

$77
Average prescription price

Avg: $58

MAYA SPODIK MD

Internal Medicine

299

$24.8K

86
60 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

0%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

33%
prescriptions for brand name drugs

Avg: 25%

$83
Average prescription price

Avg: $58

AKM RASHID M.D.

Internal Medicine

300

$4,688

188
97 are 65+

10%
patients receiving schedule two controlled substances

Avg: 7%

29%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

8%
prescriptions for brand name drugs

Avg: 25%

$16
Average prescription price

Avg: $58

RICHARD DUNBAR MD

Internal Medicine

304

$75K

35
23 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

0%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

65%
prescriptions for brand name drugs

Avg: 25%

$247
Average prescription price

Avg: $58

DANIEL RADER MD

Internal Medicine

327

$65.2K

42
35 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

0%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

79%
prescriptions for brand name drugs

Avg: 25%

$200
Average prescription price

Avg: $58

STEPHANIE WARD MD

Internal Medicine

328

$8,397

221
155 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

0%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

17%
prescriptions for brand name drugs

Avg: 25%

$26
Average prescription price

Avg: $58

IAN GAILLARD M.D.

Internal Medicine

336

$27.7K

134
113 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

0%
patients receiving schedule three controlled substances

Avg: 7%

6%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

32%
prescriptions for brand name drugs

Avg: 25%

$82
Average prescription price

Avg: $58

MD. ISLAM M.D.

Internal Medicine

337

$35.4K

63
32 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

0%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

54%
prescriptions for brand name drugs

Avg: 25%

$105
Average prescription price

Avg: $58

DAVID METZ MD

Internal Medicine

347

$106K

92
61 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

0%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 25%

$306
Average prescription price

Avg: $58

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank